Klinik Tanıdan Tedaviye Fibromiyalji: Hekimler ve Sağlık Profesyonelleri için Kapsamlı Rehber

Ablin JN, Buskila D. Update on the genetics of the fibromyalgia syndrome. Best Pract Res Clin Rheumatol. 2015;29(1):20-28. doi:10.1016/j.berh.2015.04.018.

Alsiri N, Alhadhoud M, Alkatefi T, Palmer S. The concomitant diagnosis of fibromyalgia and connective tissue disorders: a systematic review. Semin Arthritis Rheum. 2023;58:152127. doi:10.1016/j.semarthrit.2022.152127.

Altan L, Bingol U, Aykac M, Koc Z, Yurtkuran M. Investigation of the effects of pool-based exercise on fibromyalgia syndrome. Rheumatol Int. 2004;24(5):272-277. doi:10.1007/s00296-003-0371-5.

Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, et al. AAPT diagnostic criteria for fibromyalgia. J Pain. 2019;20(6):611-628. doi:10.1016/j.jpain.2018.10.008.

Arnold LM, Clauw DJ, Dunegan LJ, Turk DC. A framework for fibromyalgia management for primary care providers. Mayo Clin Proc. 2012;87(5):488-496. doi:10.1016/j.mayocp.2012.02.010.

Arnold LM, Clauw DJ, McCarberg BH, et al. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc. 2011;86(5):457-464. doi:10.4065/mcp.2010.0738.

Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, Martin SA. Patient perspectives on the impact of fibromyalgia. Patient Educ Couns. 2008;73(1):114-120. doi:10.1016/j.pec.2008.06.005.

Arnold LM, Fan J, Russell IJ, et al. The fibromyalgia family study: a genome-wide linkage scan study. Arthritis Rheum. 2013;65(4):1122-1128. doi:10.1002/art.37842.

Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, et al. Family study of fibromyalgia. Arthritis Rheum. 2004;50(3):944-952. doi:10.1002/art.20042.

Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia. Pain. 2005;119(1-3):5-15. doi:10.1016/j.pain.2005.06.031.

Atzeni F, Alciati A, Bazzichi L, et al. Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry. Clin Exp Rheumatol. 2022;40(6):1183-1188. doi:10.55563/ clinexprheumatol /64963d.

Bair MJ, Krebs EE. Fibromyalgia. Ann Intern Med. 2020;172(5 ):ITC 33-ITC48. doi:10.7326/AITC202003030.

Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4 ):R 120. doi:10.1186/ar2783.

Bennett RM, Friend R, Marcus D, et al. Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary ACR criteria. Arthritis Care Res. 2014;66(9):1364-1373. doi:10.1002/acr.22301.

Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;8:27. doi:10.1186/1471-2474-8-27.

Bernardy K, Fuber N, Klose P, Hauser W. Efficacy of hypnosis/guided imagery in fibromyalgia syndrome: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2011;12:133. doi:10.1186/1471-2474-12-133.

Bernardy K, Klose P, Busch AJ, Choy EHS, Hauser W. Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev. 2013;(9):CD009796. doi:10.1002/14651858.CD009796.pub2.

Bernardy K, Klose P, Welsch P, Häuser W. Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome. Cochrane Database Syst Rev. 2018;(9):CD009796. doi:10.1002/14651858.CD009796.pub2.

Bidonde J, Busch AJ, Schachter CL, et al. Aerobic exercise training for adults with fibromyalgia. Cochrane Database Syst Rev. 2017;(6):CD012700. doi:10.1002/14651858.CD012700.

Bidonde J, Busch AJ, Schachter CL, et al. Mixed exercise training for adults with fibromyalgia. Cochrane Database Syst Rev. 2019;(5):CD013340. doi:10.1002/14651858.CD013340.

Bidonde J, Fisher E, Perrot S, Moore RA, Makri S, Häuser W. Effectiveness of non-pharmacological interventions for fibromyalgia and quality of review methods: an overview of Cochrane Reviews. Semin Arthritis Rheum. 2023;63:152248. doi:10.1016/j.semarthrit.2023.152248.

Boomershine CS. Fibromyalgia: the prototypical central sensitivity syndrome. Curr Rheumatol Rev. 2015;11(2):131-145. doi:10.2174/1573397111666150619095007.

Borchers AT, Gershwin ME. Fibromyalgia: a critical and comprehensive review. Clin Rev Allergy Immunol. 2015;49(2):100-151. doi:10.1007/s12016-015-8509-4.

Bossema ER, van Middendorp H, Jacobs JWG, Bijlsma JWJ, Geenen R. Influence of weather on daily symptoms of pain and fatigue in female patients with fibromyalgia: a multilevel regression analysis. Arthritis Care Res (Hoboken). 2013;65(7):1019-1025. doi:10.1002/acr.22008.

Burckhardt CS, Goldenberg D, Crofford L, et al. Guideline for the management of fibromyalgia syndrome pain in adults and children. APS Clinical Practice Guidelines Series. 2005;4:1-109. Erişim: https://www.researchgate.net/publication/24180374 (çevrimiçi tam DOI bulunamadı; APS Clinical Practice Guidelines Series No. 4, 2005).

Busch AJ, Barber KAR, Overend TJ, Peloso PMJ, Schachter CL. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev. 2007;(4):CD003786. doi:10.1002/14651858.CD003786.pub2.

Buskila D, Neumann L, Hazanov I, Carmi R. Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum. 1996;26(3):605-611. doi:10.1016/s0049-0172(96)80011-4

Buskila D, Odes LR, Neumann L, Odes HS. Fibromyalgia in inflammatory bowel disease. J Rheumatol. 1999;26(5):1167-1171. https://pubmed.ncbi.nlm.nih.gov/10332985/

Çağlıyan Türk A, Şahin F. Prevalence of juvenile fibromyalgia syndrome among children and adolescents and its relationship with academic success, depression and quality of life, Çorum Province, Turkey. Arch Rheumatol. 2020;35(1):68-77. doi:10.5606/ArchRheumatol.2020.7458.

Calandre EP, Rico-Villademoros F, Slim M. An update on pharmacotherapy for the treatment of fibromyalgia. Expert Opin Pharmacother. 2015;16(9):1347-1368. doi:10.1517/14656566.2015.1047343.

Carson JW, Carson KM, Jones KD, Bennett RM, Wright CL, Mist SD. A pilot randomized controlled trial of the yoga of awareness program in the management of fibromyalgia. Pain. 2010;151(2):530-539. doi:10.1016/j.pain.2010.08.020.

Choy E, Perrot S, Leon T, Kaplan J, Petersel D, Ginovker A, Kramer E. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res. 2010;10:102. doi:10.1186/1472-6963-10-102.

Choy EHS. The role of sleep in pain and fibromyalgia. Nat Rev Rheumatol. 2015;11(9):513-520. doi:10.1038/nrrheum.2015.56.

Cifre I, Sitges C, Fraiman D, et al. Disrupted functional connectivity of the pain network in fibromyalgia. Psychosom Med. 2012;74:55-62. doi:10.1097/PSY.0b013e3182408f04.

Clauw DJ, D’Arcy Y, Gebke K, Semel D, Pauer L, Jones KD. Normalizing fibromyalgia as a chronic illness. Postgrad Med. 2018;130(1):9-18. doi:10.1080/00325481.2018.1411743.

Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y. Milnacipran for the treatment of fibromyalgia in adults: a 15-week multicenter, randomized, double-blind, placebo-controlled trial. Clin Ther. 2008;30(11):1988-2004. doi:10.1016/j.clinthera.2008.11.014.

Clauw DJ. Fibromyalgia and related conditions. Mayo Clin Proc. 2015;90(5):680-692. doi:10.1016/j.mayocp.2015.03.014.

Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547-1555. doi:10.1001/jama.2014.3266.

Clauw DJ. Treating fibromyalgia: science versus evidence. JAMA Intern Med. 2014;174(10):1561-1562. doi:10.1001/jamainternmed.2014.3390.

Clauw DJ. Why don’t we use a body map in every chronic pain patient yet? Pain. 2024;165(8):1660-1661. doi:10.1097/j.pain.0000000000003184.

Coles ML, Weissmann R, Uziel Y. Juvenile primary fibromyalgia syndrome: epidemiology, etiology, pathogenesis, clinical manifestations and diagnosis. Pediatr Rheumatol Online J. 2021;19(1):22. doi:10.1186/s12969-021-00493-6.

Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52(4):1264-1273. doi:10.1002/art.20983.

Crofford LJ. Chronic pain: where the body meets the brain. Trans Am Clin Climatol Assoc. 2015;126:167-183. https://pmc.ncbi.nlm.nih.gov/articles/PMC4530716/

Deare JC, Zheng Z, Xue CCL, Liu JP, Shang J, Scott SW, Littlejohn G. Acupuncture for treating fibromyalgia. Cochrane Database Syst Rev. 2013;(5):CD007070. doi:10.1002/14651858.CD007070.pub2.

Derry S, Gill D, Phillips T, Moore RA. Milnacipran for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2015;(10):CD008244. doi:10.1002/14651858.CD008244.pub3.

Dobkin PL, Abrahamowicz M, Fitzcharles MA, Dritsa M, da Costa D. Maintenance of exercise in women with fibromyalgia. Arthritis Rheum. 2005;53(5):724-731. doi:10.1002/art.21449.

Dobkin PL, Da Costa D, Abrahamowicz M, et al. Adherence during an individualized home based 12-week exercise program in women with fibromyalgia. J Rheumatol. 2006;33(2):333-341. https://pubmed.ncbi.nlm.nih.gov/16465666/

Döhmen A, Kock M, Fischer F, Rose M, Obbarius A, Klapproth CP. Are OMERACT recommendations followed in clinical trials on fibromyalgia? Qual Life Res. 2023;32(6):1521-1536. doi:10.1007/s11136-022-03261-5.

Duffield SJ, Miller N, Zhao S, Goodson NJ. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2018;57(8):1453-1460. doi:10.1093/rheumatology/key112.

Dumolard A, Lefaucheur JP, Hodaj E, et al. Central sensitization and small-fiber neuropathy are associated in patients with fibromyalgia. Clin J Pain. 2023;39(1):8-14. doi:10.1097/AJP.0000000000001085.

Eastwood F, Godfrey E. The efficacy, acceptability and safety of acceptance and commitment therapy for fibromyalgia: a systematic review and meta- analysis. Br J Pain. 2024;18(3):20494637231221451. doi:10.1177/20494637231221451.

Fagerlund AJ, Iversen M, Ekeland A, et al. Blame it on the weather? The association between pain in fibromyalgia, relative humidity, temperature and barometric pressure. PLoS One. 2019;14(5 ):e 0216902. doi:10.1371/journal.pone.0216902.

Filipovic T, Filipović A, Nikolic D, Gimigliano F, Stevanov J, Hrkovic M, et al. Fibromyalgia: understanding, diagnosis and modern approaches to treatment. J Clin Med. 2025;14(3):955. doi:10.3390/jcm14030955.

Fitzcharles MA, Cohen SP, Clauw DJ, Littlejohn G, Usui C, Häuser W. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021;397(10289):2098-2110. doi:10.1016/S0140-6736(21)00392-5.

Fitzcharles MA, Ste-Marie PA, Goldenberg DL, et al. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013;18(3):119-126. doi:10.1155/2013/918216.

Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M, et al. Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013;18(3):119-126. doi:10.1155/2013/918216.

Forte ML, Butler M, Andrade KE, Vincent A, Schousboe JT, Kane RL. Treatments for fibromyalgia in adult subgroups. Comparative Effectiveness Review No. 148. Rockville (MD): Agency for Healthcare Research and Quality ; 2015. https://www.ncbi.nlm.nih.gov/books/NBK274474/

Galvez-Sánchez CM, Reyes Del Paso GA. Diagnostic criteria for fibromyalgia: critical review and future perspectives. J Clin Med. 2020;9(4):1219. doi:10.3390/jcm9041219.

Giesecke T, Gracely RH, Williams DA, Geisser ME, Petzke FW, Clauw DJ. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum. 2005;52(5):1577-1584. doi:10.1002/art.21008.

Giorgi V, Bazzichi L, Salaffi F, Sarzi-Puttini P. Pharmacological treatment of fibromyalgia syndrome: a practice-based review. Curr Rheumatol Rep. 2024;26(8):501-514. doi:10.1007/s11926-024-01145-8.

Glass JM. Fibrofog and fibromyalgia: a current review of the literature. Curr Pain Headache Rep. 2006;10(5):347-352. doi:10.1007/s11916-006-0055-0.

Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292(19):2388-2395. doi:10.1001/jama.292.19.2388.

Goldenberg DL, Mayskiy M, Mossey C, Ruthazer R, Schmid C. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996;39(11):1852-1859. doi:10.1002/art.1780391110.

Goldenberg DL. Diagnosis and differential diagnosis of fibromyalgia. Am J Med. 2009;122(12 Suppl):S14-21. doi:10.1016/j.amjmed.2009.09.007.

Gowans SE, deHueck A. Effectiveness of exercise in management of fibromyalgia. Curr Opin Rheumatol. 2004;16(2):138-142. doi:10.1097/00002281-200403000-00004.

Gracely RH, Ceko M, Bushnell MC. Fibromyalgia and depression. Pain Res Treat. 2012;2012:486590. doi:10.1155/2012/486590.

Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 2002;46(5):1333-1343. doi:10.1002/art.10225.

Gür A, Cevik R, Nas K, Colpan L, Sarac S. Cortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones. Arthritis Res Ther. 2004;6(3 ):R 232-R238. doi:10.1186/ar1163.

Gür A, Cevik R, Saraç AJ, Colpan L, Em S. Hypothalamic-pituitary-gonadal axis and cortisol in young women with primary fibromyalgia: the potential roles of depression, fatigue, and sleep disturbance in the occurrence of hypocortisolism. Ann Rheum Dis. 2004;63:1504 -1506. doi:10.1136/ard.2003.014969.

Gür A, Karakoç M, Erdogan S, Nas K, Çevik R, Saraç J. Regional cerebral blood flow and cytokines in young females with fibromyalgia. Clin Exp Rheumatol 2002; (20):753-760 https://pubmed.ncbi.nlm.nih.gov/12508765/

Gür A, Karakoç M, Nas K, Cevik R, Denli A, Sarac J. Cytokines and depression in cases with fibromyalgia. J Rheumatol. 2002;29(2):358-361. https://pubmed.ncbi.nlm.nih.gov/11838856/

Gür A, Karakoç M, Nas K, Cevik R, Sarac J, Ataoglu S. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial. Rheumatol Int. 2002;22(5):188-193. doi:10.1007/s00296-002-0221-1.

Gür A, Oktayoğlu P. Advances in diagnostic and treatment options in patients with fibromyalgia syndrome. Open Access Rheumatol. 2009;1:193 -209. doi:10.2147/OARRR.S8040.

Gür A, Oktayoğlu P. Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: new concepts in treatment. Curr Pharm Des. 2008;14(13):1274-1294. doi:10.2174/138161208784246153.

Gür A, Oktayoğlu P. Status of immune mediators in fibromyalgia. Curr Pain Headache Rep. 2008;12(3):175-181. doi:10.1007/s11916-008-0032-6.

Gür A. Physical therapy modalities in management of fibromyalgia. Curr Pharm Des. 2006;12(1):29-35. doi:10.2174/138161206775193280.

Gür A. The Gür Fibromyalgia Model: A Clinically Operational Framework for Phenotype-Informed, Sequence-Sensitive Multimodal Care. Frontiers in Pain Research. 2026 (baskıda; DOI henüz atanmamış).

Gür A. Why fibromyalgia criteria keep changing: a systematic review of misclassification, measurement, and diagnostic spillover. Arch Rheumatol. 2026;41(3):155-167. doi:10.5152/ArchRheumatol.2026.26498.

Guymer EK, Littlejohn GO, Brand CK, Kwiatek RA. Fibromyalgia onset has a high impact on work ability in Australians. Intern Med J. 2016;46(9):1069-1074. doi:10.1111/imj.13135.

Harth M, Nielson WR. The fibromyalgia tender points: use them or lose them? A brief review of the controversy. J Rheumatol. 2007;34(5):914-922. https://pubmed.ncbi.nlm.nih.gov/17477475/

Hassett AL, Clauw DJ. The role of stress in rheumatic diseases. Arthritis Res Ther. 2010;12(3):123. doi:10.1186/ar3024.

Hauser W, Ablin J, Fitzcharles MA, et al. Fibromyalgia. Nat Rev Dis Primers. 2015;1:15022. doi:10.1038/nrdp.2015.22.

Hauser W, Ablin J, Perrot S, Fitzcharles MA. Management of fibromyalgia: practical guides from recent evidence-based guidelines. Pol Arch Intern Med. 2017;127(1):47-56. doi:10.20452/pamw.3877.

Hauser W, Brahler E, Wolfe F, Henningsen P. Patient Health Questionnaire 15 as a generic measure of severity in fibromyalgia syndrome. J Psychosom Res. 2014;76(4):307-311. doi:10.1016/j.jpsychores.2014.01.004.

Hauser W, Fitzcharles MA. Facts and myths pertaining to fibromyalgia. Dialogues Clin Neurosci. 2018;20(1):53-62. doi:10.31887/DCNS.2018.20.1/whauser.

Hauser W, Henningsen P. Fibromyalgia syndrome: a somatoform disorder? Eur J Pain. 2014;18(8):1052-1059. doi:10.1002/ejp.625.

Hauser W, Perrot S, Sommer C, Shir Y, Fitzcharles MA. Diagnostic confounders of chronic widespread pain: not always fibromyalgia. Pain Rep. 2017;2(3):e598. doi:10.1097/PR9.0000000000000598.

Hauser W, Petzke F, Sommer C. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain. 2010;11(6):505-521. doi:10.1016/j.jpain.2010.01.002.

Hauser W, Sarzi-Puttini P, Fitzcharles MA. Fibromyalgia syndrome: under-, over- and misdiagnosis. Clin Exp Rheumatol. 2019;37 Suppl 116(1):90-97. https://pubmed.ncbi.nlm.nih.gov/30747096/

Hauser W, Walitt B, Fitzcharles MA, Sommer C. Review of pharmacological therapies in fibromyalgia syndrome. Arthritis Res Ther. 2014;16:201. doi:10.1186/ar4441.

Hauser W, Wolfe F, Tolle T, Uceyler N, Sommer C. The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs. 2012;26(4):297-307. doi:10.2165/11598970-000000000-00000.

Iannuccelli C, Favretti M, Dolcini G, Di Carlo M, Pellegrino G, Bazzichi L, et al. Fibromyalgia: one year in review 2025. Clin Exp Rheumatol. 2025;43(6):957-969. doi:10.55563/ clinexprheumatol /buhd2z.

Ilari S, Nucera S, Malafoglia V, et al. Does vitamin D supplementation impact fibromyalgia-related pain? A systematic review and meta-analysis. Nutrients. 2025;17(20):3232. doi:10.3390/nu17203232.

Jensen KB, Loitoile R, Kosek E, et al. Patients with fibromyalgia display less functional connectivity in the brain’s pain inhibitory network. Mol Pain. 2012;8:32. doi:10.1186/1744-8069-8-32.

Jiao J, Cheng ZY, Xiao YY, et al. Validation of the 2011 and 2016 American College of Rheumatology diagnostic criteria for fibromyalgia in a Chinese population. Ann Med. 2023;55(2):2249921. doi:10.1080/07853890.2023.2249921.

Johnson MI, Claydon LS, Herbison GP, Paley CA, Jones G. Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults. Cochrane Database Syst Rev. 2017;(10):CD012172. doi:10.1002/14651858.CD012172.pub2.

Jones EA, Asaad F, Patel N, Jain E, Abd-Elsayed A. Management of fibromyalgia: an update. Biomedicines. 2024;12(6):1266. doi:10.3390/biomedicines12061266.

Jones KD, Adams D, Winters-Stone K, Burckhardt CS. A comprehensive review of 46 exercise treatment studies in fibromyalgia (1988-2005). Health Qual Life Outcomes. 2006;4:67. doi:10.1186/1477-7525-4-67.

Jurado-Priego LN, Cueto-Ureña C, Ramírez- Expósito MJ, Martínez-Martos JM. Fibromyalgia: a review of the pathophysiological mechanisms and multidisciplinary treatment strategies. Biomedicines. 2024;12(7):1543. doi:10.3390/biomedicines12071543.

Kaleycheva N, Cullen AE, Evans R, Harris T, Nicholson T, Chalder T. The role of lifetime stressors in adult fibromyalgia: systematic review and meta-analysis of case-control studies. Psychol Med. 2021;51(2):177-193. doi:10.1017/S0033291720004547.

Kang J, Timmins KA, Beasley M. Optimising fibromyalgia criteria: evidence from the UK Biobank. Semin Arthritis Rheum. 2025;74:152824. doi:10.1016/j.semarthrit.2025.152824.

Kato K, Sullivan PF, Evengard B, Pedersen NL. A population-based twin study of functional somatic syndromes. Psychol Med. 2009;39(3):497-505. doi:10.1017/S0033291708003784.

Katz RS, Wolfe F, Michaud K. Fibromyalgia diagnosis: a comparison of clinical, survey, and ACR criteria. Arthritis Rheum. 2006;54(1):169-176. doi:10.1002/art.21533.

Kia S, Choy E. Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology. Biomedicines. 2017;5(2):20. doi:10.3390/biomedicines5020020.

Kleykamp BA, Ferguson MC, McNicol E, et al. The prevalence of psychiatric and chronic pain comorbidities in fibromyalgia: an ACTTION systematic review. Semin Arthritis Rheum. 2021;51(1):166-174. doi:10.1016/j.semarthrit.2020.10.006.

Knight T, Schaefer C, Chandran A, Zlateva G, Winkelmann A, Perrot S. Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon Outcomes Res. 2013;5:171 -180. doi:10.2147/CEOR.S41111.

Kosek E, Clauw D, Nijs J, Baron R, Gilron I, Harris RE, et al. Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain. 2021;162(11):2629-2634. doi:10.1097/j.pain.0000000000002324.

Kosek E, Cohen M, Baron R, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382-1386. doi:10.1097/j.pain.0000000000000507.

Külekçioğlu S. Diagnostic difficulty, delayed diagnosis, and increased tendencies of surgical treatment in fibromyalgia syndrome. Clin Rheumatol. 2022;41(3):831-837. doi:10.1007/s10067-021-05970-7.

Kumbhare D, Raheb S, Ahmed S, Rajabali S, Bhambhani Y. Fibromyalgia diagnosis: an examination of the current criteria. Biomed Res Int. 2018;2018:9016578. doi:10.1155/2018/9016578.

Kundakci B, Kaur J, Goh SL, Hall M, Doherty M, Zhang W, et al. Efficacy of nonpharmacological interventions for individual features of fibromyalgia: a systematic review and meta-analysis of randomised controlled trials. Pain. 2022;163(8):1432-1445. doi:10.1097/j.pain.0000000000002500.

Lacasse A, Bourgault P, Choinière M. Fibromyalgia-related costs and loss of productivity: a substantial societal burden. BMC Musculoskelet Disord. 2016;17:168. doi:10.1186/s12891-016-1027-6.

Lauche R, Cramer H, Dobos G, Langhorst J, Schmidt S. A systematic review and meta-analysis of mindfulness-based stress reduction for the fibromyalgia syndrome. J Psychosom Res. 2013;75(6):500-510. doi:10.1016/j.jpsychores.2013.10.010.

Lee YH, Choi SJ, Ji JD, Song GG. Candidate gene studies of fibromyalgia: a systematic review and meta-analysis. Rheumatol Int. 2012;32(2):417-426. doi:10.1007/s00296-010-1678-9.

Li X, Zhang X, Zhou Y, et al. Guidelines on treating fibromyalgia with nonpharmacological therapies in China. J Evid Based Med. 2025:e 70044. doi:10.1111/jebm.70044.

Li Y, Wang H, Zhang Y. Pharmacologic treatment of fibromyalgia: an update. Front Pharmacol. 2025;16:1651181. doi:10.3389/fphar.2025.1651181.

Luciano JV, D’Amico F, Cerda-Lafont M, et al. Cost-utility of cognitive behavioral therapy versus FDA recommended drugs in the treatment of patients with fibromyalgia. Arthritis Res Ther. 2014;16(5):451. doi:10.1186/s13075-014-0451-y.

Lunn MPT, Hughes RAC, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014;(1):CD007115. doi:10.1002/14651858.CD007115.pub3.

Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318-328. doi:10.1136/annrheumdis-2016-209724.

Maddali Bongi S, Vitali Rosati G, Bonaccorsi G, Lorini C. Prevalence and contextual factors of juvenile fibromyalgia in a population-based Italian sample of children and adolescents. Biomedicines. 2023;11(6):1583. doi:10.3390/biomedicines11061583.

Marshall A, Elshafei M, Preston FG, Burgess J, Goodson N, Fallon N, Frank B, Zhao S, Alam U. Small fibre pathology in fibromyalgia. Pain Ther. 2025;14:461 -478. doi:10.1007/s40122-024-00696-1.

Mease PJ, Arnold LM, Crofford LJ, et al. Identifying the clinical domains of fibromyalgia: contributions from clinician and patient delphi exercises. Arthritis Rheum. 2008;59(7):952-960. doi:10.1002/art.23826.

Mezhov V, Guymer E, Littlejohn G. Central sensitivity and fibromyalgia. Intern Med J. 2021;51(12):1990-1998. doi:10.1111/imj.15455.

Mist SD, Firestone KA, Jones KD. Complementary and alternative exercise for fibromyalgia: a meta-analysis. J Pain Res. 2013;6:247-260. doi:10.2147/JPR.S32297.

Moldofsky H, Scarisbrick P, England R, Smythe H. Musculoskeletal symptoms and non-REM sleep disturbance in patients with fibrositis syndrome and healthy subjects. Psychosom Med. 1975;37(4):341-351. doi:10.1097/00006842-197507000-00008.

Moldofsky H. The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome. Joint Bone Spine. 2008;75(4):397-402. doi:10.1016/j.jbspin.2008.04.003.

Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for fibromyalgia in adults. Cochrane Database Syst Rev. 2015;(7):CD011824. doi:10.1002/14651858.CD011824.

Mork PJ, Nilsen TIL. Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway. Arthritis Rheum. 2012;64(1):281-284. doi:10.1002/art.33346.

Murphy AE, Minhas D, Clauw DJ, Lee YC. Identifying and managing nociplastic pain in individuals with rheumatic diseases: a narrative review. Arthritis Care Res (Hoboken). 2023;75(10):2215-2222. doi:10.1002/acr.25104.

Napadow V, LaCount L, Park K, et al. Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. Arthritis Rheum. 2010;62:2545-2555. doi:10.1002/art.27497.

National Institute for Health and Care Excellence. Chronic pain (primary and secondary) in over 16s: assessment and management of chronic primary pain. NICE guideline NG193. 2021. Available at: https://www.nice.org.uk/guidance/ng193. Accessed June 6, 2026.

Nijs J, George SZ, Clauw DJ, et al. Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine. Lancet Rheumatol. 2021;3(5):e383-e392. doi:10.1016/S2665-9913(21)00032-1.

Nijs J, Lahousse A, Kapreli E, Bilika P, Saraçoğlu İ, Malfliet A, et al. Nociplastic pain criteria or recognition of central sensitization? Pain phenotyping in the past, present and future. J Clin Med. 2021;10(15):3203. doi:10.3390/jcm10153203.

Nuesch E, Hauser W, Bernardy K, Barth J, Juni P. Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis. 2013;72(6):955-962. doi:10.1136/annrheumdis-2011-201249.

O’Mahony LF, Srivastava A, Mehta P, Ciurtin C. Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis. Rheumatology (Oxford). 2021;60(6):2602-2614. doi:10.1093/rheumatology/keab146.

Palstam A, Mannerkorpi K. Work ability in fibromyalgia: an update in the 21st century. Curr Rheumatol Rev. 2017;13(3):180-187. doi:10.2174/1573397113666170502152955.

Park DJ, Lee SS. New insights into the genetics of fibromyalgia. Korean J Intern Med. 2017;32(6):984-995. doi:10.3904/kjim.2016.207.

Pathak A, Kelleher EM, Brennan I, Amarnani R, Wall A, Murphy R, et al. Treatments for enhancing sleep quality in fibromyalgia: a systematic review and meta-analysis. Rheumatology (Oxford). 2025;64(8):4495-4514. doi:10.1093/rheumatology/keaf147.

Penrod JR, Bernatsky S, Adam V, Baron M, Dayan N, Dobkin PL. Health services costs and their determinants in women with fibromyalgia. J Rheumatol. 2004;31(7):1391-1398. https://pubmed.ncbi.nlm.nih.gov/15229962/

Petzke F, Clauw DJ, Ambrose K, Khine A, Gracely RH. Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of assessment. Pain. 2003;105(3):403-413. doi:10.1016/s0304-3959(03)00270-5

Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states - maybe it is all in their head. Best Pract Res Clin Rheumatol. 2011;25(2):141-154. doi:10.1016/j.berh.2011.02.005.

Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356. doi:10.1007/s11916-013-0356-5.

Rubano A, Jiroutek MR, Misciagno SA. The impact of changes in fibromyalgia diagnosis criteria: using NAMCS data (2010-2019) to identify trends. BMC Rheumatol. 2025;9:33. doi:10.1186/s41927-025-00483-1.

Sarac AJ, Gür A. Complementary and alternative medical therapies in fibromyalgia. Curr Pharm Des. 2006;12(1):47-57. doi:10.2174/138161206775193325.

Saraçoğlu İ, Neblett R, Akın E, Başakçı B, Ayhan C, Yılmaz F, et al. Is fibromyalgia a nociplastic or a mixed-pain condition? International, multidisciplinary recommendations for pain phenotyping in fibromyalgia syndrome. Pain Physician. 2025;28:483 -494. https://pubmed.ncbi.nlm.nih.gov/41337761/

Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F. Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol. 2020;16(11):645-660. doi:10.1038/s41584-020-00506-w.

Sephton SE, Salmon P, Weissbecker I, et al. Mindfulness meditation alleviates depressive symptoms in women with fibromyalgia: results of a randomized clinical trial. Arthritis Rheum. 2007;57(1):77-85. doi:10.1002/art.22478.

Sim J, Adams N. Systematic review of randomized controlled trials of nonpharmacological interventions for fibromyalgia. Clin J Pain. 2002;18(5):324-336. doi:10.1097/00002508-200209000-00007.

Siracusa R, Di Paola R, Cuzzocrea S, Impellizzeri D. Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci. 2021;22(8):3891. doi:10.3390/ijms22083891.

Sluka KA, Clauw DJ. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience. 2016;338:114 -129. doi:10.1016/j.neuroscience.2016.06.006.

Sosa- Reina MD, Nunez-Nagy S, Gallego-Izquierdo T, Pecos - Martin D, Monserrat J, Alvarez-Mon M. Effectiveness of therapeutic exercise in fibromyalgia syndrome: a systematic review and meta- analysis of randomized clinical trials. Biomed Res Int. 2017;2017:2356346. doi:10.1155/2017/2356346.

Sosa-Reina MD, Nunez-Nagy S, Gallego-Izquierdo T, Pecos-Martin D, Monserrat J, Alvarez-Mon M. Effectiveness of therapeutic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomized clinical trials. Biomed Res Int. 2017;2017:2356346. doi:10.1155/2017/2356346.

Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain. 2001;91(1-2):165-175. doi:10.1016/s0304-3959(00)00432-2

Suso-Martí L, Cuenca-Martínez F, Alba- Quesada P, et al. Effectiveness of pain neuroscience education in patients with fibromyalgia: a systematic review and meta- analysis. Pain Med. 2022;23(11):1837-1850. doi:10.1093/ pm /pnac077.

Tander B, Cengiz K, Alayli G, Ilhanli I, Canbaz S, Canturk F. A comparative evaluation of health related quality of life and depression in patients with fibromyalgia syndrome and rheumatoid arthritis. Rheumatol Int. 2008;28(9):859-865. doi:10.1007/s00296-007-0484-3.

Thieme K, Mathys M, Turk DC. Evidenced-based guidelines on the treatment of fibromyalgia patients: are they consistent and if not, why not? J Pain. 2017;18(7):747-756. doi:10.1016/j.jpain.2016.12.006.

Tomas-Carus P, Hakkinen A, Gusi N, Leal A, Hakkinen K, Ortega-Alonso A. Aquatic training and detraining on fitness and quality of life in fibromyalgia. Med Sci Sports Exerc. 2007;39(7):1044-1050. doi:10.1249/mss.0b013e31803bb4d7.

Topbas M, Cakirbay H, Gulec H, Akgol E, Ak I, Can G. The prevalence of fibromyalgia in women aged 20-64 in Turkey. Scand J Rheumatol. 2005;34(2):140-144. doi:10.1080/03009740510026337.

Toussaint LL, Vincent A, McAllister SJ, Oh TH, Bhagra A. A comparison of fibromyalgia symptoms in patients with healthy eating vs processed food diet. J Hum Nutr Diet. 2012;25(2):150-155. doi:10.1111/j.1365-277X.2011.01218.x.

Tracey I, Bushnell MC. How neuroimaging studies have challenged us to rethink: Is chronic pain a disease? J Pain. 2009;10(11):1113-1120. doi:10.1016/j.jpain.2009.09.001.

Turk DC, Adams LM. Using a biopsychosocial perspective in the treatment of fibromyalgia patients. Pain Manag. 2016;6(4):357-369. doi:10.2217/pmt-2016-0003.

Turk DC, Monarch ES, Williams AD. Psychological evaluation of patients diagnosed with fibromyalgia syndrome. Rheum Dis Clin North Am. 2002;28(2):219-233. doi:10.1016/s0889-857x(01)00002-3

Üçeyler N, Sommer C, Walitt B, Häuser W. Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev. 2013;(10):CD010782. doi:10.1002/14651858.CD010782.

van Houdenhove B, Luyten P. Stress, depression and fibromyalgia. Acta Neurol Belg. 2006;106(4):149-156. https://pubmed.ncbi.nlm.nih.gov/17323832/

van Koulil S, Effting M, Kraaimaat FW, et al. Cognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directions. Ann Rheum Dis. 2007;66(5):571-581. doi:10.1136/ard.2006.054692.

van Koulil S, van Lankveld W, Kraaimaat FW, et al. Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia. Arthritis Care Res. 2010;62(10):1377-1385. doi:10.1002/acr.20268.

Venerito V, Iannone F. Large language model-driven sentiment analysis for facilitating fibromyalgia diagnosis. RMD Open. 2024;10(2 ):e 004367. doi:10.1136/rmdopen-2024-004367.

Walitt B, Fitzcharles MA, Hassett AL, Katz RS, Häuser W, Wolfe F. The longitudinal outcome of fibromyalgia: a study of 1555 patients. J Rheumatol. 2011;38(10):2238-2246. doi:10.3899/jrheum.110026.

Wang C, Schmid CH, Rones R, et al. A randomized trial of tai chi for fibromyalgia. N Engl J Med. 2010;363(8):743-754. doi:10.1056/NEJMoa0912611.

White KP, Harth M. Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep. 2001;5(4):320-329. doi:10.1007/s11916-001-0021-2.

White KP, Speechley M, Harth M, Ostbye T. Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls. Arthritis Rheum. 1999;42(1):76-83. doi:10.1002/1529-0131(199901)42:1<76::AID-ANR10>3.0.CO;2-G

Williams DA, Arnold LM. Measures of fibromyalgia: Fibromyalgia Impact Questionnaire (FIQ), Revised Fibromyalgia Impact Questionnaire (FIQR). Arthritis Care Res. 2011;63(S11):S86-S97. doi:10.1002/acr.20543.

Williams DA, Clauw DJ, Glass JM. Perceived cognitive dysfunction in fibromyalgia syndrome. J Musculoskelet Pain. 2011;19(2):66-75. doi:10.3109/10582452.2011.558989.

Williams DA, Clauw DJ. Understanding fibromyalgia: lessons from the broader pain research community. J Pain. 2009;10(8):777-791. doi:10.1016/j.jpain.2009.06.001.

Winkelmann A, Hauser W, Friedel E, et al. Physiotherapy and physical therapies for fibromyalgia syndrome: systematic review, meta-analysis and guideline. Schmerz. 2012;26(3):276-286. doi:10.1007/s00482-012-1171-x.

Winslow BT, Vandal C, Dang L. Fibromyalgia: diagnosis and management. Am Fam Physician. 2023;107(2):137-144. https://pubmed.ncbi.nlm.nih.gov/36791450/

Wolfe F, Brahler E, Hinz A, Hauser W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res. 2013;65(5):777-785. doi:10.1002/acr.21931.

Wolfe F, Butler SH, Fitzcharles MA, Häuser W, Katz RL, Mease PJ, et al. Revised chronic widespread pain criteria: development from and integration with fibromyalgia criteria. Scand J Pain. 2019;20(1):77-86. doi:10.1515/sjpain-2019-0054.

Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62(5):600-610. doi:10.1002/acr.20140.

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, et al. 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319-329. doi:10.1016/j.semarthrit.2016.08.012.

Wolfe F, Hassett AL, Walitt B, Michaud K. Mortality in fibromyalgia: a study of 8,186 patients over thirty-five years. Arthritis Care Res. 2011;63(1):94-101. doi:10.1002/acr.20301.

Wolfe F, Michaud K, ten Klooster PM, Rasker JJ. Looking at fibromyalgia differently - an observational study of the meaning and consequences of fibromyalgia as a dimensional disorder. Semin Arthritis Rheum. 2023;58:152145. doi:10.1016/j.semarthrit.2022.152145.

Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 1990;33(2):160-172. doi:10.1002/art.1780330203.

Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2-15. doi:10.1016/j.pain.2010.09.030.

Wu E, Brener A, Hiser JKD, Hill DLK, Farmer JO. Fibromyalgia: update on pathogenesis and management. Eur J Rheumatol. 2025;12(4):0032. doi:10.5152/eurjrheum.2025.25032.

Yavne Y, Amital D, Watad A, Tiosano S, Amital H. A systematic review of precipitating physical and psychological traumatic events in the development of fibromyalgia. Semin Arthritis Rheum. 2018;48(1):121-133. doi:10.1016/j.semarthrit.2017.12.011.

Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions. Semin Arthritis Rheum. 2008;37(6):339-352. doi:10.1016/j.semarthrit.2007.09.003.

Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum. 2007;36(6):339-356. doi:10.1016/j.semarthrit.2006.11.001.